CLDN10 and nonpapillary renal cell carcinoma: However, we found that neither CLDN10 nor RASSF1A were among the top 200 CpG biomarkers in ccRCC and pRCC (TCGA), possibly indicating the uniqueness of PT-ccRCC, which we are further investigating.